Real-time Quantitative PCR Detecting System
TL998A

• Real-time Quantitative PCR Detecting System
The TL998A System provides an efficiency and high-speed solution for PCR analysis. It delivers increased sensitivity and a wider dynamic range more rapidly than traditional PCR. QPCR gives you a choice of quantitative methods for gene expression. The TL998A is very useful and important for life science research and curative evaluation, and it is innovative and pioneering products for the prevention, diagnosis, evaluation and monitoring of diseases.

• Applications

• Quantitative PCR detection in science research.

• Real-time quantitative PCR detection for clinical diagnoses, such as the infectious disease, tumor, genetic disease.

• Quantitative DNA/RNA detection of virus, such as HBV, venereal disease, etc.

• Features

• Working principle
 

•  Specifications     Reagents FAM, FITC, SYBR, various fluorescence PCR reagents, such as TaqMan probe, etc Sample capacity 48 well block Sample handing Thick-walled 0.2 ml PCR tubes Sample volume 20-100 μl Wavelength of exciting fluorescence 470 nm Wavelength of fluorescence detection 530 nm (changeable) Monochromator device Filter, made in USA Photo detector PMT (Photomultiplier tube), made in Japan Heating/cooling devices TE Peltier (Thermoelectric Peltier Effect module), made in Japan Speed of ramping of heating Up to 3 ℃/sec Speed of ramping of cooling Up to 2 ℃/sec Cycling control   Profiles 1-9 Repetitions 1-99 Steps 1-9 Set times 1-9999 sec Profile linkage Yes Thermal range 4.0 ℃-99.0 ℃ Thermal accuracy ±0.5 ℃ Thermal uniformity ±0.5 ℃ Standard curve efficiency 99.7% Dynamic Range 10 1 -10 10 Copies System interfaces RS-232C serial interface, bi-directional Computer operating system Windows 2000/XP/NT Input power AC220 ± 22V ， 50 ± 1Hz Power < 800 W Operating environment Ambient Temperature 5 ℃ -40 ℃ Relative Humidity 30%-70% Weight 15 kg Size (W×D×H) 500 mm × 400 mm × 350 mm

 

Since its establishment in 1997, Tianlong has been committed to the research and development, production and overall solutions of instruments and in vitro diagnostic reagents in the field of genetic testing and molecular diagnostics. With its own sustainable development and potential values, Tianlong has received investments from SK Group, the 57th largest company in the Fortune Global 500 list, and Kehua Bio-Engineering, a listed company in China, in 2012 and 2018.



As a high-tech enterprise in China, Tianlong Technology is responsible for many major scientific research and industrialization projects such as the National Key Research and Development Program, the National Special Project for the Development of Major Scientific Instruments and Equipment, and the National Science and Technology Support Program. ISO9001-certified and 13485-standard, Tianlong now has hundreds of products such as nucleic acid extractor, automated nucleic acid workstation, gene amplification instruments, real-time PCR instruments, ATP fluorescence detector and supporting test reagents. over 50 products have been approved by NMPA with medical device registration certificates, and more than 20 products have been approved by EU (CE) and KFDA (South Korea).



Tianlong products are widely applied in the fields of medical diagnosis, food safety, epidemic prevention and control, customs and quarantine, forensics, scientific research, etc., and have contributed to the prevention and control of various major epidemics such as avian flu, Ebola, MERS, African swine fever and neonatal pneumonia. At present, Tianlong is serving more than 2,000 customers in more than 40 countries and regions including, Korea, the United States, France, Germany, Denmark, the United Arab Emirates, Pakistan, and so on.



At the end of 2019, after the outbreak of the COVID-19 epidemic, Tianlong quickly launched SARS-CoV-2 rapid nucleic acid detection solution, successively detected the first positive samples in many provinces in China, and made a great contribution to the epidemic prevention and control globally. Tianlong successively received letters of thanks from the State Council of China, the National Center for Disease Control of China, and the Slovakian government. Tianlong was then reported by CCTV News, Xinhua News Agency, People's Daily and other authoritative media.



In the face of future opportunities and challenges, we will continue to create first-class molecular diagnostic products and work hard for human health in a more open way of cooperation with all walks of life.